Using the emergency department clinical decision unit for acute decompensated heart failure

Cardiology Clinics

Volumn 23, Issue 4, 2005, Pages 569-588

  Peacock, W Frank ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENOXAPARIN; FUROSEMIDE; GLYCERYL TRINITRATE; HYDRALAZINE; MAGNESIUM; NESIRITIDE; NITRATE; NITROPRUSSIDE SODIUM; SPIRONOLACTONE;

ACUTE HEART FAILURE; AMINO TERMINAL SEQUENCE; ARTERIAL GAS; ARTICLE; CAUSE OF DEATH; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL OBSERVATION; CONFUSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE EXACERBATION; ECONOMIC ASPECT; EMERGENCY WARD; GASTROINTESTINAL TOXICITY; HEALTH CARE COST; HEART ARRHYTHMIA; HEART BLOCK; HORMONE ACTION; HOSPITAL ADMISSION; HUMAN; HYPOKALEMIA; HYPOMAGNESEMIA; LABORATORY TEST; MEDICAL DOCUMENTATION; NEUROTOXICITY; OXYGEN SUPPLY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; THORAX RADIOGRAPHY; THROMBOEMBOLISM; VISUAL DISORDER;

EID: 27744518247     PISSN: 07338651     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccl.2005.08.014     Document Type: Review

References (100)

1. M. Packer, and J.N. Cohn Consensus recommendations for the management of chronic heart failure Am J Cardiol 83 2A 1999 1A 38A
2. B.M. Massie, and N.B. Shah Evolving trends in epidemiologic factors of heart failure: rationale for preventative strategies and comprehensive disease management Am Heart J 133 1997 703 712
3. CMS 2001 in-patient discharge data base: MEDPAR, DRG 427.
4. W.F. Peacock 4th, E.E. Remer, and J. Aponte Effective observation unit treatment of decompensated heart failure Congest Heart Fail 8 2002 68 73
5. USDHHS: Heart failure: evaluation and care of patients with left-ventricular systolic dysfunction (Clinical Practice Guideline, Number 11, AHCPR publication No. 94-0612). US Department of Health and Human Services, Washington, DC, June, 1994.
6. P.R. Marantz, J.N. Tobin, and S. Wassertheil-Smoller The relationship between left ventricular systolic function and congestive heart failure diagnosed by clinical criteria Circulation 77 1988 607 612
7. R.E. Hobbs, and M.D. Czerska Congestive heart failure. Current and future strategies to decrease mortality Postgrad Med 96 1994 167 172
8. L.E. Clemens, R.G. Almirez, and K.A. Baudouin Pharmacokinetics and biological actions of subcutaneously administered human brain natriuretic peptide J Pharmacol Exp Ther 87 1998 67 71
9. K. Nakao, M. Mukoyama, and K. Hosoda Biosynthesis, secretion, and receptor selectivity of human brain natriuretic peptide Can J Physiol Pharmacol 59 1991 1500 1506
10. M.R. Cowie, A.D. Struthers, and D.A. Wood Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care Lancet 350 1997 1349 1353
11. J. Mair, S. Thomas, and B. Puschendorf Natriuretic peptides in assessment of left-ventricular dysfunction Scan J Clin Invest 9 Suppl 230 1999 132 142
12. A.D. Struthers Ten years of natriuretic peptide research: a new dawn for their diagnostic and therapeutic use? BMJ 308 1994 1615 1619
13. W.F. Peacock, C.L. Emerman, and M. Doleh The incidence of elevated cardiac enzymes in decompensated heart failure Acad Emerg Med 5 2001 552
14. W.F. Peacock, T. DeMarco, C.L. Emerman, and J. Wynne Heart failure with an elevated troponin is associated with increased morbidity and mortality: an ADHERE registry analysis Ann Emerg Med 44 4 2004 S72
15. J. Remes, H. Miettinen, and A. Reunanen Validity of clinical diagnosis of heart failure in primary health care Eur Heart J 12 1991 315 321
16. L.W. Stevenson The limited availability of physical signs for estimating hemodynamics in chronic heart failure JAMA 261 1998 884 888
17. A.P. Davis, C.M. Francis, and M.P. Love Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction Br Med J 312 1996 222
18. P.R. Marantz, M.C. Kaplan, and M.H. Alderman Clinical diagnosis of congestive heart failure in patients with acute dyspnea Chest 97 1990 776 781
19. S. Chakko, D. Woska, and H. Marinez Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care Am J Med 90 1991 353 359
20. T. Kono, M. Suwa, and H. Hanada Clinical significance of normal cardiac silhouette in dilated cardiomyopathy; evaluation based upon echocardiography and magnetic resonance imaging Jpn Circ J 56 1992 359 365
21. J.A. Ruskin, J.W. Gurney, and M.K. Thorsen Detection of pleural effusions on supine chest radiographs AJR Am J Roentgenol 148 1987 681 683
22. A. Chait, H.E. Cohen, and L.E. Meltzer The bedside chest radiograph in the evaluation of incipient heart failure Radiology 105 1972 563 566
23. S.M. Butman, G.A. Ewy, and J.R. Standen Bedside cardiovascular examination in patients with severe chronic heart failure: importance of resting or inducible jugular venous distention J Am Coll Cardiol 22 1993 968 974
24. P.R. Marantz, M.C. Kaplan, and M.H. Alderman Clinical diagnosis of congestive heart failure in patients with acute dyspnea Circulation 88 1993 107 115
25. W.F. Peacock, P. Kies, and N.M. Albert Bioimpedance monitoring for detecting pulmonary fluid in heart failure: equal to chest radiography? Congest Heart Fail 6 2000 86 89
26. Q. Dao, P. Krishnaswamy, and R. Kazanegra Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting J Am Coll Cardiol 37 2001 379 385
27. P.A. McKee, W.P. Castelli, and P.M. McNamara The natural history of congestive heart failure: The Framingham Study N Engl J Med 285 1971 1441 1446
28. C.M. Francis, L. Caruana, and P. Kearney Open access echocardiography in management of heart failure in the community BMJ 310 1995 634 636
29. ACC/AHA. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult. [Cited March 18, 2002]. Available from: http://www.acc.org/clinical/guidelines/failure/I_introduction.
30. N.M. Wheeldon, T.M. MacDonald, and C.J. Flucker Echocardiography in chronic heart failure in the community Q J Med 86 1993 255 261
31. K. Maeda, T. Tsutamoto, and A. Wada Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction Am Heart J 135 1998 825 832
32. K. Yamamoto, J.C. Burnett, and M. Jougasaki Superiority of brain natriuretic peptide as a humoral marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy Hypertension 28 1996 988 994
33. T. Omland, A. Aakvaag, and V. Bonarjee Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide Circulation 93 1996 1963 1969
34. R. Kazanegra, V. Cheng, and A. Garcia A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study J Card Fail 7 2001 21 29
35. K.T. Jensen, J. Carstens, and P. Ivarsen A new, fast and reliable radioimmunoassay of brain natriuretic peptide in human plasma. Reference values in healthy subjects and in patients with different diseases Scand J Clin Lab Invest 57 1997 529 540
36. M.G. Buckley, N.D. Markandu, and M.A. Miller Plasma concentrations and comparisons of brain and atrial natriuretic peptide in normal subjects and in patients with essential hypertension J Hum Hypertens 3 1993 345 350
37. T. Wallen, T. Landahl, and T. Herner Brain natriuretic peptide in an elderly population J Intern Med 242 1997 307 311
38. H. Sayama, Y. Nakamura, and N. Saito Relationship between left ventricular geometry and brain natriuretic peptide levels in elderly subjects Gerontology 46 2000 71 77
39. B. Lernfelt Aging and left ventricular function in elderly healthy people Am J Cardiol 68 1991 547 549
40. K.P. Kohse Differential regulation of brain and atrial natriuretic peptides in hemodialysis patients Clin Nephrol 40 1993 83 90
41. P.A. McCullough, P. Duc, and T. Omland B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study Am J Kidney Dis 41 3 2003 571 579
42. V. Cheng, R. Kazanagra, and A. Garcia A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study J Am Coll Cardiol 37 2001 386 391
43. W.H. Tang, J.P. Girod, and M.J. Lee Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure Circulation 108 24 2003 2964 2966
44. H. Niinuma, M. Nakamura, and K. Hirarnori Plasma B-type natriuretic peptide measurement in a multiphasic health screening program Cardiology 90 1998 89 94
45. M. Davis, E. Espiner, and G. Richards Plasma brain natriuretic peptide in assessment of acute dyspnoea Lancet 343 1994 440 444
46. T.A. McDonagh, S.D. Robb, and J.J. Morton Biochemical detection of left-ventricular systolic dysfunction Lancet 351 1998 9 13
47. A.S. Maisel, P. Krishnaswamy, and R.M. Nowak Breathing Not Properly Multinational Study Investigators. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 347 2002 161 167
48. P. Bettencourt, A. Ferreira, and P. Dias Evaluation of brain natriuretic peptide in the diagnosis of heart failure Cardiology 93 2000 19 25
49. M. Fujimora, Y. Yasumura, and Y. Ishida Improvement in left ventricular function in response to carvedilol is accompanied by attenuation of neurohumoral activation in patients with dilated cardiomyopathy J Card Fail 6 2000 3 10
50. T. Nishikimi, H. Matsuoka, and K. Ishikawa Antihypertensive therapy reduces increased plasma levels of adrenomedullin and brain natriuretic peptide concomitant with regression of left ventricular hypertrophy in a patient with malignant hypertension Hypertens Res 19 1996 97 101
51. P. Selvais, J. Donckier, and R. Laloux Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation Eur J Clin Invest 28 1998 636 642
52. T. Tsutamoto, A. Wada, and K. Maeda Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction Eur Heart J 20 1999 1799 1807
53. C.M. Yu, and J.E. Sanderson Plasma brain natriuretic peptide - an independent predictor of cardiovascular mortality in acute heart failure Eur J Heart Fail 1 1999 59 65
54. A. Hammerer-Lercher, E. Neubauer, and S. Muller Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction Clin Chim Acta 310 2001 193 197
55. A. Harrison, L.K. Morrison, and P. Krishnaswamy B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea Ann Emerg Med 39 2002 131 138
56. A.C. Arroliga Noninvasive positive pressure ventilation in acute respiratory failure: does it improve outcomes? Cleve Clin J Med 68 2001 677 680
57. W.F. Peacock, C.L. Emerman, and M.R. Costanzo Early initiation of intravenous therapy improves heart failure outcomes: an analysis from the ADHERE registry database Ann Emerg Med 42 4 2003 S26
58. W.F. Peacock 4th, and N.M. Albert Observation unit management of heart failure Emerg Med Clin North Am 19 2001 209 232
59. W.F. Peacock, J.H. Aponte, and M.T. Craig Inpatient versus emergency department observation unit management of heart failure Ann Emerg Med 32 1998 S46
60. G.C. Fonarow, K.F. Adams Jr., and W.T. Abraham The ADHERE Scientific Advisory Committee, Study Group, and Investigators Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis JAMA 293 2005 572 580
61. D.B. Diercks, J.D. Kirk, W.F. Peacock, and J.E. Weber Identification of emergency department patients with decompensated heart failure at low risk for adverse events and prolonged hospitalization J Cardiac Failure 10 4 2004 S114
62. J. Burkhardt, W.F. Peacock, and C.L. Emerman Elevation in blood urea nitrogen predicts a lower discharge rate from the observation unit Ann Emerg Med 44 4 2004 S99
63. M.W. Rich, V. Beckham, and C. Wittenberg A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure N Engl J Med 333 1995 1190 1195
64. M.W. Rich, J.M. Vinson, and J.C. Sperry Prevention of readmission in elderly patients with congestive heart failure J Gen Intern Med 8 1993 585 590
65. N.M. Albert, and W.F. Peacock Patient outcome and costs after implementation of an acute heart failure management program in an emergency department observation unit J Int Soc Heart Lung Transplant 18 1999 92
66. J.M. Vinson, M.W. Rich, and J.C. Sperry Early readmission of elderly patients with congestive heart failure J Am Geriatr Soc 38 1990 1290 1295
67. S.E. Quaglietti, J.E. Atwood, and L. Ackerman Management of the patient with congestive heart failure using outpatient, home, and palliative care Prog Cardiovasc Dis 43 2000 259 274
68. W. Peacock, J. Aponte, and M. Craig Predictors of unsuccessful treatment for congestive heart failure in the emergency department observation unit Acad Emerg Med 4 1997 494
69. J.N. Cohn, G. Johnson, and S. Ziesche A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure N Engl J Med 325 1991 303 310
70. J.N. Cohn, D.G. Archibald, and S. Ziesche Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of the Veterans Administration Cooperative Study N Engl J Med 314 1986 1547 1552
71. The SOLVD Investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure N Engl J Med 325 1991 293 302
72. The CONSENSUS Trial Study Group Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS) N Engl J Med 315 1987 1429 1435
73. L.S. Marcus, D. Hart, and M. Packer Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. A double-blind, placebo-controlled, randomized crossover trial Circulation 94 1996 3184 3189
74. W.T. Abraham, B.D. Lowes, and D.A. Ferguson Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure J Card Fail 4 1998 37 44
75. A.J. Burger, D.P. Horton, and U. Elkayam Nesiritide is not associated with the proarrhythmic effects of dobutamine in the treatment of decompensated CHF: The PRECEDENT Study J Card Fail 5 Suppl 1 1999 178
76. U. Elkayam, M.A. Silver, and A.J. Burger The effect of short-term therapy with nesiritide (B-type natriuretic peptide) or dobutamine on long-term survival J Card Fail 6 Suppl 2 2000 169
77. J.B. Young, L.W. Stevenson, and W.T. Abraham Rationale and design of the VMAC Trial: Vasodilation in the Management of Acute Congestive Heart Failure J Card Fail 6 Suppl 2 2000 182
78. W.S. Colucci, U. Elkayam, and D.P. Horton Nesiritide Study Group: intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group N Engl J Med 343 2000 246 253
79. M.A. Silver, J.K. Ghali, and D.P. Horton Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of acutely decompensated heart failure J Card Fail 4 Suppl 1 1998 150A
80. Peacock WF, Emerman CE, Young J, on behalf of the PROACTION study group. Safety and efficacy of nesiritide for the treatment of decompensated heart failure in emergency department observation unit patients. JACC 2003;4(6)(Suppl A):336A.
81. W.S. Colucci, M. Packer, and M.R. Bristow US Carvedilol Study Group: carvedilol inhibits clinical progression in patients with mild symptoms of heart failure Circulation 94 1996 2800 2806
82. R.T. Tsuyuki, S. Yusuf, and J.L. Rouleau Combination neurohormonal blockade with ACE inhibitors, angiotensin II, antagonists and beta-blockers in patients with congestive heart failure: design of the Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVED) pilot study (phase II) Eur Heart J 19S 1998 308
83. The International Steering Committee Rationale, design, and organization of the Metoprolol CR/XL randomized intervention trial in heart failure (MERIT-HF) Am J Cardiol 80 Suppl 9B 1997 54J 58J
84. CIBIS Investigators and Committees A randomized trial of beta-blockade in heart failure: The Cardiac Insufficiency Bisoprolol Study (CIBIS) Circulation 90 1994 1765 1773
85. M.R. Bristow, E.M. Gilbert, and W.T. Abraham MOCHA Investigators: carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure Circulation 94 1996 2807 2816
86. The Rales Investigators Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (The Randomized Aldactone Evaluation Study [RALES]) Am J Cardiol 78 1996 902 907
87. G. Cioffi, M. Pozzoli, and G. Forni Systemic thromboembolism in chronic heart failure. A prospective study in 406 patients Eur Heart J 17 1996 1381 1389
88. D.W. Baker, and R.F. Wright Management of heart failure. IV. Anticoagulation for patients with heart failure due to left ventricular systolic dysfunction JAMA 272 1994 1614 1618
89. A.G. Turpie Thrombosis prophylaxis in the acutely ill medical patient: insights from the prophylaxis in MEDical patients with ENOXaparin (MEDENOX) trail AJC 86 12B 2000 48M 52M
90. ACC/AHA Guidelines for the evaluation and management of heart failure: report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee of Evaluation and Management of Heart Failure) Circulation 92 1995 2764 2784
91. U. Elkayam, L. Weber, and C. McKay Spectrum of acute hemodynamic effects of nifedipine in severe congestive heart failure Am J Cardiol 56 1985 560 566
92. J.N. Barjon, J.L. Rouleau, and D. Bichet Chronic renal and neurohumoral effects of the calcium entry blocker nisoldipine in patients with congestive heart failure J Am Coll Cardiol 9 1987 622 630
93. U. Elkayam, J. Amin, and A. Mehra A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure Circulation 82 1990 1954 1961
94. R.E. Goldstein, S.J. Boccuzzi, and D. Cruess Diltiazem increases late-onset congestive heart failure in post-infarction patients with early reduction in ejection fraction. The Adverse Experience Committee and the Multicenter Diltiazem Post-infarction Research Group Circulation 83 1991 52 60
95. W.P. Batsford, L.L. Mickleborough, and J.A. Elefteriades Ventricular arrhythmias in heart failure Cardiol Clin 13 1995 87 91
96. The Cardiac Arrhythmia Suppression Trail (CAST) Investigators Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction N Engl J Med 321 1989 406 412
97. N.M. Albert Manipulating survival and life quality outcomes in heart failure through disease state management Crit Care Nurse Clin North Am 11 1999 121 141
98. C.M.J. Cline, B.Y.A. Israelsson, and R.B. Willenheimer Cost effective management program for heart failure reduces hospitalization Heart 80 1998 442 446
99. G.C. Fonarow, L.W. Stevenson, and J.A. Walden Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure J Am Coll Cardiol 30 1997 725 732
100. W. Gattis, V. Hasselblad, and D. Whellan Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team Arch Intern Med 159 1999 1939 1945